Basic Information
ID: ALA4682406
Type: Functional
Description: Anticancer activity against human HepG2 cells assessed as reduction in cell viability by MTT assay
Format: BAO_0000219
Organism: Homo sapiens
Cell type: HepG2
Target: HepG2(ALA395)
Document: ALA4680119
Anticancer activity against human HepG2 cells assessed as reduction in cell viability by MTT assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4682406
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 543.53 | 0.00 | 0.00 |
| 404.43 | 3.27 | 3.27 |
| 443.38 | 4.87 | 4.87 |
| 541.48 | 5.44 | 5.44 |
| 622.38 | 6.13 | 6.13 |
| 510.51 | 5.84 | 5.84 |
| 519.48 | 6.64 | 6.64 |
| 541.48 | 5.44 | 5.44 |
| 504.54 | 4.83 | 4.83 |
| 375.38 | 3.94 | 3.94 |
| 533.51 | 6.95 | 6.95 |
| 496.48 | 5.53 | 5.53 |
| 510.51 | 5.84 | 5.84 |
| 544.41 | 6.69 | 6.69 |
| 496.48 | 5.53 | 5.53 |
| 488.38 | 4.78 | 4.78 |
| 479.54 | 5.55 | 5.55 |
| 776.81 | 8.41 | 8.41 |
| 575.38 | 6.29 | 6.29 |
| 465.51 | 5.55 | 5.55 |
| 492.75 | 5.68 | 5.68 |
| 564.48 | 6.55 | 6.55 |
| 541.48 | 5.44 | 5.44 |
| 575.38 | 6.29 | 6.29 |
| 477.52 | 6.02 | 6.02 |
| 577.38 | 6.23 | 6.23 |
| 389.41 | 4.33 | 4.33 |
| 499.95 | 6.58 | 6.58 |